Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
COVID-19 News New study finds strong immune response following COVID-19 vaccination A new study carried out in collaboration with the University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
COVID-19 New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
Posted 11 June 2021 Fighting the silent pandemic of anti-microbial resistance An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.
Posted 04 June 2021 Study of UK dental professionals reveals extent of occupational risk of SARS-CoV-2 infection A University of Birmingham-led study of over a thousand dental professionals has shown their increased occupational risk of SARS-CoV-2 infection during the first wave of the pandemic in the UK.
Posted 04 June 2021 Many patients with COVID-19 produce immune responses against their body's own tissues or organs, finds study A University of Birmingham-led study funded by the UK Coronavirus Immunology Consortium has found that many patients with COVID-19 produce immune responses against their body's own tissues or organs.
Posted 14 May 2021 Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people, finds study New study finds that antibody response in people over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer COVID-19 vaccine after 12 weeks compared to at a three-week interval.
Posted 12 May 2021 Study launches to investigate immune response to SARS-CoV-2 infection in patients with antibody deficiencies A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
Posted 11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs– new study A new approach to tackling viruses by targeting the 'control centre' in viral RNA could lead to broad spectrum anti-viral drugs and provide a first line of defence against future pandemics, according to new research.